Press release
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
View report:https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights
Key players developing potential TNF-a drug candidates have been profiled in the report. Each of the company profile provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.
Advent Tumor Necrosis Factor Alpha (TNF-a) inhibitors represent one a major treatment paradigm for inflammatory diseases. Anti TNF-a drug class one of the most commercially successful drug classes in the pharmaceutical industry worldwide. Currently marketed anti-TNF-a drugs are among the top five global block buster drugs. Cumulative sales of top three TNF-a inhibitors (Remicade, Enbrel, Humira) surpassed $32 billion in 2016.
TNF-a inhibitors exhibit therapeutic efficacy blocking the activity of tumor necrosis factor (TNF), a cytokine that causes inflammation and leads to diverse immune-system diseases. Apparently, almost all the currently marketed TNF-a drugs are indicated for wide spectrum of immune-related disorders such as – Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and uveitis. Advances in biological research is uncovering further therapeutic benefits of this drug class for wider indications. Currently clinical research is focused on evaluating therapeutic efficacy and safety of TNF-a inhibitors on wide range of other inflammatory diseases, neurodegenerative diseases and multiple cancers.
Reasons to buy
To gain erudite insights on TNF-a inhibitor pipeline landscape
Ascertain unique product development dynamics and leverage it for novel target identification, drug repositioning and precision medicine.
For optimization of pipeline product portfolio in correspondence with ever dynamic pharmaceutical market
Identify competitors and design strategic initiatives for drug development activities
To understand the market and choose right partners for strategic collaborations
To obtain well-informed updates on drug termination/drug discontinuations
Related Reports
1) Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights
2) Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/chimeric-antigen-receptor-car-t-cell-immunotherapy-pipeline-insights-2017
About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017 here
News-ID: 785375 • Views: …
More Releases from Arizton Advisory & Intelligence
U.S. IT Staffing Market Size to Reach USD 44.50 Billion by 2031, Growing at a CA …
The U.S. IT staffing landscape is undergoing a massive structural transformation. We are moving away from the era of bulk hiring generalists and entering a highly polarized, skills-first market driven by infrastructure demands and automated efficiency.
Whether you are an enterprise tech leader trying to fill critical pipeline gaps, a specialized contractor navigating the new wave, or a talent strategist mapping out the next few years, understanding these numbers and trends…
UAE Construction Equipment Market Size to Reach 18.15 Thousand Units by 2031 as …
UAE Construction Equipment Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031.
According to recent research by Arizton, the UAE construction equipment market was estimated at 14.07 thousand units in 2025 and is expected to reach 18.15 thousand units by 2031, growing at a CAGR of 4.34% during the forecast period. Continued investments in infrastructure and urban development, along with the UAE's economic diversification strategy,…
Europe Data Center Colocation Market Investment to Reach USD 46.51 Billion by 20 …
Europe Data Center Colocation Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031
According to recent research by Arizton, the Europe data center colocation market by investment was valued at USD 11.65 billion in 2025 and is expected to reach USD 46.51 billion by 2031, growing at a CAGR of 25.94%. Western Europe is expected to account for approximately USD 33.17 billion, representing 71.3% of…
Global Precision Parts Market Size to Reach USD 376.96 Billion by 2031, with APA …
Precision Parts Market Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2026-2031.
According to recent research by Arizton, the global precision parts market was valued at USD 264.82 billion in 2025 and is expected to reach USD 376.96 billion by 2031, growing at a CAGR of 6.06% during the forecast period. Market growth is being driven by rising aerospace and defense manufacturing investments, advancements in precision…
More Releases for TNF
The Prevalence Of Inflammatory Diseases Driving Tnf Alpha Inhibitor Market Growt …
The TNF Alpha Inhibitors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the TNF Alpha Inhibitors Market?
The TNF alpha inhibitors market has seen modest growth in recent years. It is expected to increase from $43.09 billion in 2024 to…
The Prevalence Of Inflammatory Diseases Driving Tnf Alpha Inhibitor Market Growt …
The TNF Alpha Inhibitors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the TNF Alpha Inhibitors Market?
The TNF alpha inhibitors market has seen modest growth in recent years. It is expected to increase from $43.09 billion in 2024 to…
Transforming the TNF Alpha Inhibitors Market in 2025: The Prevalence Of Inflamma …
What Is the Expected Size and Growth Rate of the TNF Alpha Inhibitors Market?
There has been a slight increase in the size of the TNF alpha inhibitors market in the recent past. Projected growth of this market is from $43.09 billion in 2024, rising to $43.57 billion in 2025, indicating a compound annual growth rate of 1.1%. The historic period's growth can be tied to a combination of factors, such…
Transforming the TNF Alpha Inhibitors Market in 2025: The Prevalence Of Inflamma …
What Is the Expected Size and Growth Rate of the TNF Alpha Inhibitors Market?
There has been a slight increase in the size of the TNF alpha inhibitors market in the recent past. Projected growth of this market is from $43.09 billion in 2024, rising to $43.57 billion in 2025, indicating a compound annual growth rate of 1.1%. The historic period's growth can be tied to a combination of factors, such…
Introduction to Tumor Necrosis Factor (TNF) Inhibitors
Tumor Necrosis Factor (TNF) inhibitors are a class of medications that have revolutionized the treatment of autoimmune diseases and inflammatory conditions. TNF is a cytokine, a protein involved in immune system signaling, that plays a central role in the inflammatory response. While TNF is essential for fighting infections and controlling immune reactions, excessive or uncontrolled TNF activity can lead to chronic inflammation, contributing to various autoimmune diseases such as rheumatoid…
TNF Inhibitors Market to Witness an Outstanding Growth by 2030
The TNF Inhibitors Market 2024 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics archive of market research studies. It offers detailed research and analysis of key aspects of the global TNF Inhibitors market. This global report explores the key factors affecting the growth of the dynamic TNF Inhibitors market, including…
